GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wai Yuen Tong Medicine Holdings 897.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.36

—

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2025

Revenue

HK$745.3m

FY2016FY2025

Net income

HK$7.1m

FY2016FY2025

Free cash flow

HK$75.2m

FY2016FY2025

Shareholders' equity

HK$1.18bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueHK$745.3mHK$783.9mHK$723.6mHK$1.39bnHK$1.11bnHK$620.7mHK$751.4mHK$845.8mHK$738.4mHK$825.3m
Gross profitHK$376.5mHK$394.8mHK$342.4mHK$570.4mHK$439.0mHK$281.6mHK$301.5mHK$343.8mHK$310.8mHK$370.2m
Operating income−HK$40.9mHK$48.8mHK$11.2mHK$118.6mHK$40.7m−HK$114.6m−HK$129.8m−HK$97.7m−HK$23.4mHK$16.0m
Net incomeHK$7.1m−HK$15.4m−HK$20.5m−HK$108.9m−HK$376.0mHK$438.5mHK$74.6m−HK$115.6m−HK$93.3mHK$25.4m
Diluted earnings per share0.01-0.02-0.01-0.09-0.310.360.06-0.09-0.110.07

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsHK$1.74bnHK$2.10bnHK$7.01bnHK$7.60bnHK$7.96bnHK$7.73bnHK$3.45bnHK$3.66bnHK$3.57bnHK$3.24bn
Cash and short-term investmentsHK$146.6mHK$196.8mHK$579.3mHK$645.2mHK$666.6mHK$591.0mHK$903.3mHK$548.4mHK$474.0mHK$402.7m
Total liabilitiesHK$554.2mHK$708.2mHK$4.66bnHK$5.08bnHK$5.40bnHK$5.09bnHK$1.01bnHK$1.10bnHK$921.5mHK$915.0m
DebtHK$435.4mHK$560.1mHK$1.76bnHK$1.80bnHK$1.77bnHK$1.76bnHK$852.2mHK$927.0mHK$759.3mHK$738.7m
Shareholders' equityHK$1.18bnHK$1.39bnHK$2.35bnHK$2.52bnHK$2.57bnHK$2.64bnHK$2.44bnHK$2.55bnHK$2.65bnHK$2.32bn
Shares outstanding1,126m1,181m1,216m1,232m1,232m1,232m1,248m1,265m883m342m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsHK$102.3mHK$191.7mHK$168.3mHK$152.3mHK$412.6m−HK$32.5m−HK$26.6m−HK$76.7m−HK$89.9m−HK$115.7m
Capital spending−HK$27.2m−HK$34.6m−HK$33.4m−HK$26.0m−HK$59.5m−HK$6.8m−HK$17.0m−HK$63.6m−HK$78.4m−HK$282.1m
Free cash flowHK$75.2mHK$157.0mHK$134.9mHK$126.2mHK$353.0m−HK$39.3m−HK$43.6m−HK$140.3m−HK$168.3m−HK$397.8m
Dividends paid−HK$199.1m—————————

Latest quarters

By quarter end

Sept 2025Mar 2025Sept 2024Mar 2024Sept 2023Mar 2023Sept 2022Mar 2022
RevenueHK$322.8mHK$398.5mHK$346.8mHK$105.1mHK$368.3mHK$117.5mHK$606.1mHK$735.3m
Gross profitHK$165.3mHK$194.4mHK$182.0mHK$70.8mHK$186.2mHK$84.6mHK$257.8mHK$295.2m
Operating income−HK$16.1m−HK$29.7m−HK$10.4m−HK$51.1mHK$25.9m−HK$8.8mHK$20.1mHK$70.0m
Net incomeHK$2.8m−HK$16.6mHK$23.7m−HK$18.9mHK$3.5mHK$32.9m−HK$53.4m−HK$123.0m
Diluted earnings per share0.00-0.010.02-0.03-0.000.03-0.04-0.10
Cash from operationsHK$36.0mHK$68.0mHK$33.0mHK$124.0mHK$67.0mHK$167.0m—HK$181.0m
Capital spending−HK$8.0m−HK$12.0m−HK$14.0mHK$9.0m−HK$44.0m−HK$14.0m−HK$18.0m−HK$14.0m
Free cash flowHK$28.0mHK$56.0mHK$19.0mHK$133.0mHK$23.0mHK$153.0m—HK$167.0m
Total assetsHK$1.69bnHK$1.74bnHK$1.77bnHK$2.10bnHK$6.58bnHK$7.01bnHK$6.91bnHK$7.60bn
Cash and short-term investmentsHK$135.7mHK$146.6mHK$113.5mHK$196.8mHK$505.4mHK$579.3mHK$635.0mHK$645.2m
Debt—HK$155.9mHK$162.8mHK$276.2mHK$877.7mHK$1.03bnHK$1.22bnHK$1.04bn
Shareholders' equityHK$1.18bnHK$1.18bnHK$1.20bnHK$1.39bnHK$2.23bnHK$2.35bnHK$2.26bnHK$2.52bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-18.8%3.7%-1.1%
Operating income—-18.6%-2.6%
Net income—-56.2%-24.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.4%46.2%44.7%43.6%
Operating margin0.5%3.8%1.2%-2.4%
Net margin-0.5%-3.8%-1.4%-0.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings61.8-20.0-6.4-1.1-0.30.31.4-0.7-0.91.4
Price to sales0.60.40.20.10.10.20.10.10.10.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 22 Aug 2024.

FY2025FY2015FY2014FY2012
Paid in the year0.1470.060.060.06
  • 20-to-1 reverse split · 16 Mar 2016
  • 25-to-1 reverse split · 22 Sept 2010
  • 10-to-1 reverse split · 9 Jun 2005
  • 1.319-for-1 split · 28 May 2004
  • 100-to-1 reverse split · 20 Oct 2003

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.